| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2725001 | The American Journal of Medicine | 2008 | 11 Pages |
Abstract
Metformin treatment in persons at risk for diabetes improves weight, lipid profiles, and insulin resistance, and reduces new-onset diabetes by 40%. The long-term effect on morbidity and mortality should be assessed in future trials.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Shelley R. MD, Nicholas S. Buckley, Justin A. Kahn, Edwin E. PhD,